BioRem Inc. (TSXV:BRM)

BioRem Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	42.36	37.42	25.17	28.86	24.48
Revenue Growth (YoY)	13.19%	48.69%	-12.81%	17.91%	0.42%
Cost of Revenue	29.59	27.36	18.14	20.1	18.24
Gross Profit	12.77	10.06	7.02	8.76	6.24
Selling, General & Admin	6.14	5.62	3.91	5.79	3.91
Research & Development	0.05	0.04	0.03	0.1	0.01
Other Operating Expenses	0.08	0.05	0.02	0.24	0.24
Total Operating Expenses	6.28	5.71	3.96	6.12	4.17
Operating Income	6.49	4.34	3.06	2.64	2.07
Interest Expense	-0.16	-0.2	-0.27	-0.26	-0.04
Total Non-Operating Income (Expense)	-0.16	-0.2	-0.27	-0.26	-0.04
Pretax Income	6.33	4.15	2.79	2.38	2.03
Provision for Income Taxes	1.51	1.1	0.61	0.77	0.74
Net Income	4.82	3.04	2.18	1.61	1.3
Net Income to Common	4.82	3.04	2.18	1.61	1.3
Net Income Growth	58.25%	39.66%	35.11%	24.34%	-37.89%
Shares Outstanding (Basic)	16	16	16	15	36
Shares Outstanding (Diluted)	19	19	17	18	37
Shares Change (YoY)	-0.40%	9.40%	-2.55%	-53.08%	-5.32%
EPS (Basic)	0.30	0.19	0.14	0.10	0.04
EPS (Diluted)	0.26	0.16	0.13	0.09	0.03
EPS Growth	62.50%	23.08%	41.48%	164.97%	-30.64%
Shares Outstanding	16.13	16.14	15.7	15.5	15.48
Free Cash Flow	7.27	3.31	-0.06	1.24	3.71
Free Cash Flow Growth	119.45%	-	-	-66.50%	23.48%
Free Cash Flow Per Share	0.39	0.18	-0.00	0.07	0.10
Gross Margin	30.14%	26.87%	27.90%	30.36%	25.48%
Operating Margin	15.32%	11.61%	12.17%	9.15%	8.46%
Profit Margin	11.37%	8.13%	8.66%	5.59%	5.30%
FCF Margin	17.17%	8.85%	-0.25%	4.30%	15.14%
EBITDA	6.96	4.82	3.45	2.99	2.41
EBITDA Margin	16.44%	12.87%	13.69%	10.36%	9.86%
EBIT	6.49	4.34	3.06	2.64	2.07
EBIT Margin	15.32%	11.61%	12.17%	9.15%	8.46%
Effective Tax Rate	23.89%	26.63%	21.86%	32.32%	36.23%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.